Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA CANCER SPIT TEST DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORKS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN CANCER BURDEN WORLDWIDE
6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS
6.1.3 RISE IN GERIATRIC POPULATION
6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER
6.1.5 RISE IN EXPENDITURE ON HEALTHCARE
6.2 RESTRAINTS
6.2.1 INCREASE PREVALENCE OF COVID-19
6.2.2 LACK OF EARLY DETECTION
6.3 OPPORTUNITIES
6.3.1 RECOMMENDATIONS FOR CANCER SCREENING
6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING
6.3.3 RISE IN R&D ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT REGULATION POLICY
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS
7 IMPACT OF COVID-19 THE ON NORTH AMERICA CANCER SPIT TEST DEVICES MARKET
7.1 IMPACT ON SUPPLY CHAIN
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS FOR MANUFACTURERS
7.4 CONCLUSION
8 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SALIVA COLLECTION KIT
8.2.1 DNA EXTRACT
8.2.2 RNA EXTRACT
8.3 FLUID SPECIFIC DEVICES
8.4 ORAL SWAB
8.5 BAR-CODE LABELS
8.6 SALIVA CRYOSTORAGE BOX
8.7 OTHERS
9 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION
9.1 OVERVIEW
9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND
9.3 PAROTID GLAND
9.4 MINOR SALIVARY GLAND
10 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 LIVER-LUNG CANCER
10.3 BREAST CANCER
10.4 COLON AND RECTAL CANCER
10.5 PROSTATE CANCER
10.6 PANCREATIC CANCER
10.7 ORAL CANCER
10.8 THYROID CANCER
10.9 ENDOMETRIAL CANCER
10.1 KIDNEY CANCER
10.11 LEUKEMIA
10.12 MELANOMA
10.13 NON-HODGKIN LYMPHOMA
10.14 OTHERS
11 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION
12.1 OVERVIEW
12.2 PASSIVE DROOL
12.3 ORAL SWAB
12.4 OTHERS
13 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ONCOLOGY SPECIALITY CLINICS
13.5 CANCER RESEARCH INSTITUTES
13.6 OTHERS
14 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 OTHERS
15 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY REGION
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
16 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BIOCARTIS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BD
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 F. HOFFMANN-LA ROCHE LTD
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 QIAGEN
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AGILENT TECHNOLOGIES, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 BIOMÉRIEUX SA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANVAX
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 COLOR HEALTH, INC.
18.9.1 1.6.1 COMPANY SNAPSHOT
18.9.2 1.6.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 DNA GENOTEK
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENT
18.11 ILLUMINA, INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 MIRACLEAN TECHNOLOGY CO.,LTD.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 OASIS DIAGNOSTICS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 PERIRX
18.14.1 COMPANY SNAPSHOT
18.14.2.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SALIMETRICS, LLC
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 SARSTEDT AG & CO. KG
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 THERMO FISHER SCIENTIFIC INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.
TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.
TABLE 3 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 U.S. CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.S. SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 57 U.S. CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 58 U.S. CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 U.S. CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 60 U.S. CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 61 U.S. CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 U.S. CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 63 CANADA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 CANADA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 CANADA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 66 CANADA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 CANADA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 68 CANADA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 69 CANADA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 CANADA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 MEXICO CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 MEXICO SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 73 MEXICO CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 74 MEXICO CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 MEXICO CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 76 MEXICO CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 77 MEXICO CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 MEXICO CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 2 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS
FIGURE 4 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE NORTH AMERICA CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 SALVIA COLLECTION KIT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CANCER SPIT TEST DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA CANCER SPIT TEST DEVICES MARKET
FIGURE 14 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 15 ESTIMATED AGE-STANDARDIZED INCIDENCE RATES (WORLD) IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 16 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2020
FIGURE 17 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 18 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2020
FIGURE 21 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, CAGR (2021-2028)
FIGURE 23 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, LIFELINE CURVE
FIGURE 24 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2020
FIGURE 25 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2020
FIGURE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2021-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 32 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2020
FIGURE 33 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, LIFELINE CURVE
FIGURE 36 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, 2020
FIGURE 37 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, 2021-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, LIFELINE CURVE
FIGURE 40 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 42 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 43 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: SNAPSHOT (2020)
FIGURE 45 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020)
FIGURE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)
